Novo Nordisk to Invest 'Significantly' in Supply Chain Resilience - CEO

Reuters2022-03-24

Diabetes and obesity drug maker Novo Nordisk will invest "significantly" in its supply chain capacity to avoid future supply shortages, the company's CEO Lars Jorgensen told its annual general meeting...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
9